Constitutively active EGFR variants can induce immune suppression in lung cancers through their ability to shed mutant EGFR-containing exosomes into infiltrating dendritic cells, abrogating their ability to present tumor antigens [74]. The gene discussed is EGFR; the disease is lung cancer.